OTC Nasal Antiseptic NanoBio Protect ‘Lethal’ In COVID-19 In Vitro Tests, Amazon Launch Soon
BlueWillow Biologics points to recent in vitro tests it conducted with Public Health England showing NanoBio Protect killed COVID-19 as additional support for using nasal antiseptics to help prevent infections from the novel coronavirus. The firm also will soon offer sales of NanoBio Protect on Amazon.
You may also be interested in...
“When COVID-19 hit, we really decided to accelerate plans,” says BlueWillow CEO Dave Peralta. NanoBio Protect contains OTC monograph ingredient benzalkonium chloride in a proprietary nanotechnology, alcohol-free formulation to help reduce germs on skin inside and around the nose that could cause infections.
Recent US consumer health and beauty product recalls also include three shades of lip moisturizer with sunscreen, made by Pfizer and marketed by GSK due to a packaging problem. A Florida firm recalled one lot of a CBD oil tincture after a state agency’s test found high lead levels.
FTC nearly doubles its total of warnings on false and misleading COVID-19 claims for consumer health products with 50 announced on 21 May. WHO reported the same day that the largest number of COVID-19 cases, more than 106,000, were recorded in any 24-hour period during the pandemic.